Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 11.86M P/E - EPS this Y 59.70% Ern Qtrly Grth -
Income -1.81M Forward P/E - EPS next Y 62.80% 50D Avg Chg -24.00%
Sales 441.25k PEG - EPS past 5Y - 200D Avg Chg -24.00%
Dividend N/A Price/Book N/A EPS next 5Y - 52W High Chg -75.00%
Recommedations 2.50 Quick Ratio 1.54 Shares Outstanding 1.86M 52W Low Chg 7.00%
Insider Own 19.37% ROA -95.59% Shares Float 1.50M Beta -
Inst Own 3.02% ROE - Shares Shorted/Prior 54.30K/104.84K Price 2.13
Gross Margin - Profit Margin - Avg. Volume 3,300,662 Target Price 5.50
Oper. Margin -3,332.34% Earnings Date - Volume 241,386 Change -0.93%
About 60 Degrees Pharmaceuticals, Inc

60 Degrees Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States. The company offers Arakoda for malaria preventative treatment. It also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19 indications; Tafenoquine, which is in phase IIA clinical trials for babesiosis, fungal pneumonias, and candidiasis disease; and Celgosivir for respiratory viruses and dengue. The company was founded in 2010 and is headquartered in Washington, the District of Columbia.

60 Degrees Pharmaceuticals, Inc News
11/22/24 60 Degrees Pharmaceuticals and Can-Fite BioPharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
11/14/24 60 Degrees Pharmaceuticals Inc. (SXTP) Reports Q3 Loss, Misses Revenue Estimates
11/14/24 60 Degrees Pharmaceuticals Announces Third Quarter 2024 Results
10/03/24 60 Degrees Pharmaceuticals Inc. Announces ARAKODA® Promotional Pilot in Advance of Expanded U.S. Launch
09/06/24 60 Degrees Pharmaceuticals, Inc. Announces Closing of $4 Million Private Placement Priced At-the-Market Under Nasdaq Rules
09/04/24 60 Degrees Pharmaceuticals, Inc. Announces $4 Million Private Placement Priced At-the-Market Under Nasdaq Rules
08/28/24 60 Degrees Pharmaceuticals, Inc. Regains Compliance with Nasdaq Listing Requirements
08/17/24 60 Degrees Pharmaceuticals Second Quarter 2024 Earnings: Misses Expectations
08/14/24 60 Degrees Pharmaceuticals Inc. (SXTP) Reports Q2 Loss, Tops Revenue Estimates
08/14/24 60 Degrees Pharmaceuticals Announces Second Quarter 2024 Results
08/12/24 Should You Add 60 Degrees Pharmaceuticals, Inc. (SXTP) to Your Stock Portfolio Right Now?
08/12/24 60 Degrees Pharma Provides University of Kentucky with Right of Reference to ARAKODA® NDA in Support of SJ733 Phase IIb Study
08/06/24 60 Degrees Pharmaceuticals, Inc. Announces 1:12 Reverse Stock Split
07/25/24 60 Degrees Pharmaceuticals Awarded Contract with U.S. Army for ARAKODA® Supply Chain Upgrade Support
07/22/24 60 Degrees Pharmaceuticals enters deals for babesiosis treatment trial
07/19/24 60 Degrees Pharmaceuticals Signs Clinical Trial Agreements With All Planned Trial Sites for Tafenoquine Babesiosis Study
07/09/24 60 Degrees Pharma Announces IRB Approval of Clinical Study of Tafenoquine for Treatment of Babesiosis in Immunocompromised Patients with Persistent Babesia microti Despite Prior Treatment
06/27/24 First Patient Enrolled in 60 Degrees Pharmaceuticals Clinical Trial of Tafenoquine for Babesiosis at Tufts Medical Center; First and Only Study of Its Kind
06/11/24 60 Degrees Pharmaceuticals Receives FDA Orphan Drug Designation for Tafenoquine for Treatment of Patients with Acute Babesiosis
05/30/24 Enrollment in 60 Degrees Pharmaceuticals Clinical Trial of Tafenoquine for Babesiosis to Begin at Tufts Medical Center; First Study of Its Kind
SXTP Chatroom

User Image Stocksrockman Posted - 6 minutes from now

$ABVE adding more and more Monday morning and probably more overnight $SXTP buy the dip $ww ww $WTO dip $ARTW is moving back up

User Image TheTradeXchange Posted - 1 day ago

$SXTP CANF 60 Degrees Pharmaceuticals and Can-Fite BioPharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

User Image CEOBuysDisclosures Posted - 1 day ago

$SXTP CEO purchased 7,000 shares at $0.91 for a total of $6,367. DOW GEOFFREY S now owns 76,225 shares. https://ceo-buys.com

User Image Buying_another Posted - 1 week ago

$SXTP yawn

User Image bugjun3 Posted - 1 week ago

$SXTP Soon!

User Image isaacwilliams33 Posted - 2 weeks ago

$SXTP

User Image 1FARMMAN Posted - 2 weeks ago

$SXTP SXTP stock under the Base Case scenario is 8.73 USD. Compared to the current market price of 1.1 USD, 60 Degrees Pharmaceuticals Inc is Undervalued by 87%.

User Image mgogel Posted - 2 weeks ago

$SXTP it’s a trap

User Image mgogel Posted - 2 weeks ago

$SXTP this is a huge buy

User Image AceTunes Posted - 2 weeks ago

$SXTP slowly and steady wins the race

User Image bugjun3 Posted - 2 weeks ago

$SXTP Soon!!

User Image bigkilla Posted - 2 weeks ago

$SXTP

User Image mgogel Posted - 2 weeks ago

$SXTP what is this

User Image AceTunes Posted - 2 weeks ago

$SXTP In and early. The fireworks start above $!

User Image GJ_Rockabilt Posted - 2 weeks ago

$SXTP After Hours gift from Bears? Who is first?

User Image FloraWin Posted - 2 weeks ago

🚨 MYNZ HUGE PR drop incoming before the Nov 13 meeting 🔥 Someone is pushing these dates of upcoming NEWS 3 biggest stock alert channels announced, might consider to add now, who knows. $SXTP $SXTC $NCPL $YCBD

User Image hitmongreen Posted - 2 weeks ago

$SXTP 🧐, remember who was here

User Image bugjun3 Posted - 3 weeks ago

$SXTP Anytime now!! 🚀🚀

User Image ai36r Posted - 3 weeks ago

$SXTP 💚 $ 4.00 + LFG!

User Image AceTunes Posted - 10/30/24

$SXTP hidden gem

User Image GJ_Rockabilt Posted - 10/29/24

$SXTP According to GlobeNewsWire, "ARAKODA is the only FDA-approved prophylactic therapy approved by the U.S. Food and Drug Administration (“FDA”) that provides protection against all stages of malaria. Further, ARAKODA is recommended as a Prevention for travelers to malaria-endemic regions, due in part to its convenient weekly dosing regimen and established safety profile." On October 3rd, 60 Degrees Pharmaceuticals reported they "commenced a nine-month promotional pilot to bring greater awareness of ARAKODA and its benefits to patients and healthcare providers who prescribe it."

User Image bugjun3 Posted - 10/29/24

$SXTP Soon ! 🚀🚀

User Image RealErnFranklin Posted - 10/26/24

$POAI i can buy and hold put me in your group $SXTP needs a thin up day $HWH looks like loading idk ( $ATPC omg getting the fomo for monday , no saying hold it but a trade opp)

User Image Slayer69 Posted - 10/25/24

$SXTP I have to ask but what kind of retard sells 150 shares @ .8003 right after the close?

User Image 1FARMMAN Posted - 10/25/24

$SXTP wait for it it will run like $XPON anytime!

User Image bugjun3 Posted - 10/24/24

$SXTP waiting patiently!

User Image BULLETSTOCK Posted - 10/24/24

$SXTP Could Boom Like $CCTG keep it on your radar loaded. W > $MLGO $TVGN

User Image TheBattleDude Posted - 1 month ago

$SXTP huh interesting .91 I'll start lightly see where this goes

User Image bugjun3 Posted - 1 month ago

$SXTP She waking up !!

User Image Danyman Posted - 1 month ago

$DRUG $SXTP can do it from $1,2 like Drug. Low marketcap.🚀

Analyst Ratings
HC Wainwright & Co. Neutral Sep 13, 24
HC Wainwright & Co. Neutral Aug 15, 24
HC Wainwright & Co. Neutral Jun 6, 24
HC Wainwright & Co. Neutral Apr 3, 24
HC Wainwright & Co. Neutral Oct 20, 23
Ascendiant Capital Buy Oct 2, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
DOW GEOFFREY S President and CEO President and CEO Jan 31 Buy 0.375 25,974 9,740 703,599 02/02/24
XU CHERYL Director Director Jan 31 Buy 0.38 200,000 76,000 424,934 02/02/24